![Jonathan Sporn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Sporn
Fondateur chez Gilgamesh Pharmaceuticals, Inc.
Postes actifs de Jonathan Sporn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
Fondateur | - | - | |
President | - | - |
Historique de carrière de Jonathan Sporn
Anciens postes connus de Jonathan Sporn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Fondateur | - | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Founder | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Health Services |
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Jonathan Sporn
- Expérience